Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis. Morihara H, Yamada T, Tona Y, Akasaka M, et al. PLoS One 2024;19:e0305984.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Morihara H, Yamada T, Tona Y, Akasaka M, et al. Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis. PLoS One 2024;19:e0305984.
PMID: 39106430